Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts NAUT Hot Sheet
Join SI Premium – FREE
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q2 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $190 thousand.
For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood Ventures Fund II opens at $22.50, IPO at $25
- Sandisk targets mid-to-high teens revenue growth through FY2030
- Jefferies sees a buying opportunity in this S&P 500 sector
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
